ANNX
Price
$4.89
Change
-$0.30 (-5.78%)
Updated
Feb 13 closing price
Capitalization
728.88M
22 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$2.23
Change
-$0.01 (-0.45%)
Updated
Feb 13 closing price
Capitalization
140.82M
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs PRLD

Header iconANNX vs PRLD Comparison
Open Charts ANNX vs PRLDBanner chart's image
Annexon
Price$4.89
Change-$0.30 (-5.78%)
Volume$1.9M
Capitalization728.88M
Prelude Therapeutics
Price$2.23
Change-$0.01 (-0.45%)
Volume$127.07K
Capitalization140.82M
ANNX vs PRLD Comparison Chart in %
ANNX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANNX vs. PRLD commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (ANNX: $4.89 vs. PRLD: $2.23)
Brand notoriety: ANNX and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 72% vs. PRLD: 28%
Market capitalization -- ANNX: $727.39M vs. PRLD: $140.82M
ANNX [@Biotechnology] is valued at $727.39M. PRLD’s [@Biotechnology] market capitalization is $140.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANNX and PRLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while PRLD’s TA Score has 6 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 4 bearish.
  • PRLD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а -14.66% price change this week, while PRLD (@Biotechnology) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 09, 2026.

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANNX($729M) has a higher market cap than PRLD($141M). ANNX YTD gains are higher at: -2.590 vs. PRLD (-23.103). PRLD has higher annual earnings (EBITDA): -119.27M vs. ANNX (-216.47M). ANNX has more cash in the bank: 189M vs. PRLD (55M). PRLD has less debt than ANNX: PRLD (17.9M) vs ANNX (26.9M). PRLD has higher revenues than ANNX: PRLD (10.5M) vs ANNX (0).
ANNXPRLDANNX / PRLD
Capitalization729M141M517%
EBITDA-216.47M-119.27M181%
Gain YTD-2.590-23.10311%
P/E RatioN/AN/A-
Revenue010.5M-
Total Cash189M55M344%
Total Debt26.9M17.9M150%
TECHNICAL ANALYSIS
Technical Analysis
ANNXPRLD
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGORX25.020.31
+1.25%
Lord Abbett Growth Opportunities R3
DALVX22.620.14
+0.62%
Dunham Large Cap Value A
DIFAX12.930.05
+0.39%
MFS Diversified Income A
INVNX19.430.02
+0.10%
Evolutionary Tree Innovators I
PTPPX17.27N/A
N/A
Principal International Equity R5

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been closely correlated with ERAS. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ANNX jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-5.78%
ERAS - ANNX
73%
Closely correlated
-2.52%
ACET - ANNX
71%
Closely correlated
+2.83%
TERN - ANNX
71%
Closely correlated
+0.11%
RVMD - ANNX
70%
Closely correlated
-1.05%
CGEM - ANNX
70%
Closely correlated
-0.86%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with IPSC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-0.45%
IPSC - PRLD
54%
Loosely correlated
N/A
IMNM - PRLD
54%
Loosely correlated
-1.25%
INBX - PRLD
53%
Loosely correlated
-7.68%
TRDA - PRLD
52%
Loosely correlated
+0.74%
ANNX - PRLD
52%
Loosely correlated
-5.78%
More